Skip to Content

Zentek Ltd ZEN

Morningstar Rating
CAD 1.55 −0.04 (2.52%)
View Full Chart
Unlock our analysis with Morningstar Investor

About Quantitative Ratings

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.

Price vs Fair Value

ZEN is trading at a 748% premium.
Price
CAD 1.54
Fair Value
CAD 4.40
Uncertainty
Extreme
1-Star Price
CAD 77.91
5-Star Price
CAD 8.25
Economic Moat
Fsbqh
Capital Allocation
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if ZEN is a good fit for your portfolio.

Trading Information

Previous Close Price
CAD 1.59
Day Range
CAD 1.551.62
52-Week Range
CAD 1.302.30
Bid/Ask
CAD 1.55 / CAD 1.58
Market Cap
CAD 156.18 Mil
Volume/Avg
14,070 / 43,032

Key Statistics

Price/Earnings (Normalized)
Price/Sales
3,509.93
Dividend Yield (Trailing)
Dividend Yield (Forward)
Total Yield
0.22%

Company Profile

Zentek Ltd is an IP development and commercialization company focused on next-gen healthcare solutions in the areas of prevention, detection, and treatment. It is focused on commercializing ZENGuard, a patent-pending coating with 99% antimicrobial activity, including against COVID-19, and the potential to use similar compounds as pharmaceutical products against infectious diseases. The company also has an exclusive agreement to be the global commercializing partner for a newly developed, highly scalable, aptamer-based rapid pathogen detection technology.
Sector
Healthcare
Industry
Medical Instruments & Supplies
Stock Style Box
Small Growth
Total Number of Employees
31

Comparables

Valuation

Metric
ZEN
SCLX
206640
Price/Earnings (Normalized)
13.96
Price/Book Value
13.112.02
Price/Sales
3,509.932.302.84
Price/Cash Flow
9.42
Price/Earnings
ZEN
SCLX
206640

Financial Strength

Metric
ZEN
SCLX
206640
Quick Ratio
3.960.123.86
Current Ratio
6.050.155.09
Interest Coverage
−121.66−66.4789.20
Quick Ratio
ZEN
SCLX
206640

Profitability

Metric
ZEN
SCLX
206640
Return on Assets (Normalized)
−34.48%−107.39%13.00%
Return on Equity (Normalized)
−63.64%15.76%
Return on Invested Capital (Normalized)
−37.71%13.96%
Return on Assets
ZEN
SCLX
206640
See how this stock stacks up to its competitors with Morningstar Investor

Medical Instruments & Supplies Industry Comparables

Ticker
Name
Morningstar Rating for Stocks
Capital Allocation
Economic Moat
Market Cap
ISRG
Intuitive Surgical IncNfxvcjymfJxc$140.6 Bil
BDX
Becton Dickinson & CoKltvzgdkPfckgc$68.3 Bil
ALC
Alcon IncSnvnbrsDcyvcgj$43.6 Bil
RMD
ResMed IncFzjkcqbrvNcbzcnb$32.3 Bil
CLPBY
Coloplast A/S ADRFgwjcxjhwPrbx$27.9 Bil
WST
West Pharmaceutical Services IncLkzfjvxxzbJxjrr$25.9 Bil
COO
The Cooper Companies IncLfydblsfPwkyx$19.3 Bil
BAX
Baxter International IncQrnjjzrrVbsyzh$18.1 Bil
HOLX
Hologic IncPghyymqhmLnsjyk$17.5 Bil
TFX
Teleflex IncNgwrSmpz$10.3 Bil

Sponsor Center